Hexima Limited
Sydney
About Hexima Limited
Hexima is a clinical-stage anti-infectives biotechnology company that is developing plant defensin peptides for human therapeutic applications. They provide treatment for toenail fungal infections and onychomycosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Funding stage: IPO
- Last round: Debt Financing (Jul 2009)
- Ticker: asx:HXL
- Website: hexima.com.au
- Phone: [email protected]
Industries & Categories
Biotechnology, Product Research
Social Profiles
Canonical: https://fsome.com/organization/hexima-limited-2096260 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.